Free Trial

InnovAge (OTCMKTS:INNV) Share Price Crosses Above 50 Day Moving Average - Should You Sell?

InnovAge logo with Medical background

Key Points

  • InnovAge Holding Corp. (OTCMKTS: INNV) shares surpassed their fifty-day moving average of $3.81, reaching a high of $4.63 during trading.
  • The company's market capitalization is approximately $623.76 million with a price-to-earnings ratio of -14.90, indicating potential concerns about profitability.
  • InnovAge specializes in providing medical and ancillary services for seniors, operating through a Program of All-Inclusive Care for the Elderly (PACE) approach.
  • Five stocks we like better than InnovAge.

InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $3.81 and traded as high as $4.63. InnovAge shares last traded at $4.62, with a volume of 45,027 shares changing hands.

InnovAge Trading Up 11.3%

The business's 50 day moving average price is $3.81 and its two-hundred day moving average price is $3.57. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $623.76 million, a price-to-earnings ratio of -14.90 and a beta of 0.52.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in InnovAge Right Now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.